 @article{Eskandari_2020, title={Regulatory T cells engineered with TCR signalingâ€“responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter}, volume={12}, ISSN={1946-6242}, url={http://dx.doi.org/10.1126/scitranslmed.aaw4744}, DOI={10.1126/scitranslmed.aaw4744}, number={569}, journal={Science Translational Medicine}, publisher={American Association for the Advancement of Science (AAAS)}, author={Eskandari, Siawosh K. and Sulkaj, Ina and Melo, Mariane B. and Li, Na and Allos, Hazim and Alhaddad, Juliano B. and Kollar, Branislav and Borges, Thiago J. and Eskandari, Arach S. and Zinter, Max A. and Cai, Songjie and Assaker, Jean Pierre and Choi, John Y. and Al Dulaijan, Basmah S. and Mansouri, Amr and Haik, Yousef and Tannous, Bakhos A. and van Son, Willem J. and Leuvenink, Henri G. D. and Pomahac, Bohdan and Riella, Leonardo V. and Tang, Li and Seelen, Marc A. J. and Irvine, Darrell J. and Azzi, Jamil R.}, year={2020}, month=nov }
